The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma

Cancer

Volumn 86, Issue 8, 1999, Pages 1455-1462

  Saito, Hiroaki ^a   Tsujitani, Shunichi ^a   Oka, Shinichi ^a   Kondo, Akira ^a   Ikeguchi, Masahide ^a   Maeta, Michio ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Gastric carcinoma; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STATISTICS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033570029     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L     Document Type: Article

References (51)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes Memorial Award Lecture. Cancer Res 1986;46:467-73.
2. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 1990;82:4-6.
3. Weider N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
4. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992;340:145-7.
5. Weider N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
6. Smith-MacCune KK, Weider N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994;54:800-4.
7. Takahashi Y, Kitadai Y, Bucana CD, Cleary K, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
8. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996;56:2671-6.
9. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997;15:826-32.
10. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T. Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas. Br J Cancer 1997;75:566-71.
11. Tanimoto H, Yoshaida K, Yokozaki H, Yasui W, Nakaama H, Ito H, et al. Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch B Cell Pathol 1991;61:263-7.
12. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-63.
13. Maeda K, Chung YS, Takatsuka S, Kang SM, Ogawa M, Sawada T, et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73:884-8.
14. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998;152: 93-100.
15. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992;119:1017-21.
16. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res 1992;52:6949-52.
17. Jasani B, Wyllie FS, Wright PA, Lemoine NR, Williams ED, Wynford-Thomas D. Immunocytochemically detectable TGF beta is associated with malignancy in thyroid epithelial neoplasia. Growth Factors 1990;2:149-55.
18. Johnson MD, Federspiel CF, Gold LI, Moses HL. Transforming growth factor beta and transforming growth factor beta receptor expression in human meningioma cells. Am J Pathol 1992;141:633-42.
19. Friess H, Yamanaka Y, Büchler MW, Ebert M, Beger HG, Gold LI, et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-56.
20. Naef M, Ishiwata T, Friess H, Büchler MW, Gold LI, Korc M. Differential localization of transforming growth factor-β isoforms in human gastric mucosa and overexpression in gastric carcinoma, Int J Cancer 1997;71:131-7.
21. Hirayama D, Fujimori T, Satonaka K, Nakamura T, Kitazawa S, Horio M, et al. Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastric cancer. Hum Pathol 1992;23: 681-5.
22. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H. Immonoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative differences between cancer and stromal cells. Cancer Res 1993;53:183-90.
23. Yanagihara K, Tsumuraya M. Transforming growth factor beta 1 induces apoptosis cell death in cultured human gastric carcinoma cells. Cancer Res 1992;52:4042-5.
24. Robert AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. Transforming growth factor beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
25. Pepper MS, Berlin D, Montesano R, Orci L, Vassalli JD. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990;111: 743-55.
26. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
27. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, et al. Vascular endothelial growth factor is induced in response to transforming growth factor β in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-4.
28. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Tokyo: Kanehara & Co. Ltd., 1995.
29. Saito H, Tsujitani S, Ikeguchi M, Naeta M, Kaibara N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 1998;78:1573-7.
30. Saito H, Tsujitani S, Kondo A, Ikeguchi M, Maeta M, Kaibara N. The expression of vascular endothelial growth factor (VEGF) correlates with hematogenous recurrence in gastric carcinoma. Surgery 1999;125:195-201.
31. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 1996;2:1679-84.
32. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
33. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203-8.
34. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333-40.
35. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;34:19761-8.
36. Goldberg MA, Schneider J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994;269:4355-9.
37. Rak J, Mitsuhashi Y, Bakyo L, Filmus J, Shirakawa S, Sasazuki T, et al. Mutant ras oncogene up-regulate VEGF/VPF expression: implication for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575-80.
38. Keiser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase-C induction of vascular endothelial growth factor expression. Oncogene 1994;9:963-9.
39. Takahashi Y, Bucana CD, Cleary KR, Ellis LM. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 1998;79:34-8.
40. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N. Neoangiogenesis and relation to nuclear p53 accumulation and vascular endothelial growth factor (VEGF) expression in advanced gastric carcinoma. Oncology 1999;57:164-72.
41. Dolecki GJ, Connolly DT. Effects of a variety of cytokines and including agents on vascular permeability factor mRNA levels in U973 cells. Biochem Biophys Res Commun 1991; 180:572-8.
42. Goad DL, Rubin J, Wang H, Tashjian AH, Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 1996; 137:2262-8.
43. Kim KW, Bae SK, Lee OH, Bae MH, Lee MJ, Park BC. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 1998;58:348-51.
44. Yamamoto S, Yasui W, Kitadai Y, Yokozaki H, Haruma K, Kajiyama G, et al. Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int 1998;48:499-506.
45. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-41.
46. DeLarco JE, Todaro GJ. Growth factor from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 1978;75: 4001-5.
47. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, et al. Transforming growth factor-β-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 1991;146:1077-82.
48. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenese, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 1989;264:1860-9.
49. Laiho M, Keski-Oja J. Growth factor in the regulation of pericellular proteolysis: a review. Cancer Res 1989;49:2533-53.
50. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 1991;266:11436-41.
51. Horimoto M, Kato J, Takimoto R, Terui T, Mogi Y, Niitsu Y. Identification of a transforming growth factor beta-1 activator derived from a human gastric cancer cell line. Br J Cancer 1995;72:676-82.